Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more
There are no team members found

The Lipidomics platform, part of the Metabolomics SRF at NDM, supports the identification and quantification of lipids in physiological samples, including cells, media, serum/plasma, and tissue. We are equipped with Targeted and unbiased (Untargeted) lipidomics capabilities.

Instrumentation:  Agilent Technologies 6495 Triple Quad LC/MS (suitable for Targeted Lipidomics) and Thermo Scientific Q Exactive LC/MS (suitable for Untargeted Lipidomics).

Team Members:

- Dr. Adán Pinto-Fernández

- Dr. Simeon Draganov

- Prof. Benedit Kessler

- Dr. Zhanru Yu

Publications:

1. "Targeted Mass Spectrometry Reveals Interferon-Dependent Eicosanoid and Fatty Acid Alterations in Chronic Myeloid Lukaemia" by Scott H. et al. (2024). Full access to the article in the following link: https://www.mdpi.com/1422-0067/24/21/15513

2. "Altered Hormone and Bioactive Lipid Plasma Profile in Rodent Models of Polycystic Ovarian Syndrome Revealed by Targeted Mass Spectrometry" by Scott H. et al. (2025). Full access to the article in the following link: https://jem.elmerpub.com/jem/article/view/1514